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Abstract Wereviewtheimagingfindingsofpediatricgastro-
enteropancreatic neuroendocrine tumors (GEP-NETs) using
contemporary anatomic and molecular imaging techniques.
A low index of suspicion can result in significant delays in
diagnosis of pediatric GEP-NETs. A multimodality imaging
approach, using both anatomic and functional imaging, is
essential in the diagnosis, staging, and surveillance of these
potentially malignant tumors.
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Introduction
Neuroectodermal tumors arising from the neural crest, such
as neuroblastomas, form a large proportion of childhood
neoplasms. Gastroenteropancreatic neuroendocrine tumors
(GEP-NETs) are a small subgroup of neural crest tumors
whose imaging findings are not well described in children.
These tumors arise from neuroendocrine cells found in the
pancreas, the gut, and its derivatives including the bronchial
tree. The term “neuroendocrine tumors” encompasses
carcinoid tumors, islet cell tumors, and amine precursor
uptake and decarboxylation (APUD) tumors. Although
these tumors can produce distinct clinical syndromes
because of their secretory capacity, they are underdiagnosed
in children, resulting in delays in detection [1, 2]. The small
size of the primary tumor and its tendency to occur
anywhere along the gastroenteropancreatic (GEP) system
can make detection a challenge. Advances in anatomic
imaging and incorporation of metabolic imaging techniques
have led to improved detection of these tumors.
Since 1990, 13 patients 21 years of age or younger were
seen at our hospital with a diagnosis of a GEP-NET. The
primaries were located in the pancreas (n=4), lung (n=4),
appendix (n=1), thymus (n=1) and middle ear (n=1), and
in two patients the tumor was primary unknown. Six
patients had functional tumors and were symptomatic for
several months to 5 years (mean 2 years) with symptoms
including diarrhea, peptic ulcer disease, abdominal pain,
and weight loss. Metastases were present in 50% of these
patients by the time a GEP-NET was diagnosed. Two of the
three patients with pulmonary NET tumors presented with
recurrent pneumonia. One patient with an unsuspected NET
developed carcinoid crisis after resection of the tumor and
required intensive care management. One patient had a
history of a familial disorder, von Hippel-Lindau (VHL)
disease, predisposing to NET.
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Classification
GEP-NETshavetraditionallybeenclassifiedintotwogroups:
(1) carcinoids, which are subdivided by their origin into
tumors of the foregut (lung, thymus, stomach, duodenum),
midgut (jejunum, ileum, appendix, right colon), and hindgut
(left colon, rectum); and (2) pancreatic tumors [3]. A more
prognostically useful classification was proposed by the
WorldHealthOrganizationin2000:well-differentiatedNETs,
which show benign behavior (group 1a); well-differentiated
neuroendocrine carcinomas (NEC), which are characterized
by low-grade malignancy (group 1b); and poorly differenti-
ated NEC of high-grade malignancy (group 2) [4].
Based on their clinical features, these tumors can be
functional or nonfunctional. Functional tumors have clinical
symptoms caused by hypersecretion of hormones such as
gastrin, while nonfunctional tumors can produce clinically
silenthormonessuchaspancreaticpolypeptide.Thesetumors
often produce more than one hormone, and the functional
tumors are named according to the hormone responsible for
the clinical syndrome, for example gastrinoma causing
Zollinger-Ellison syndrome and insulinoma causing hypo-
glycemic syndrome. NETs can either be sporadic or occur
as part of familial syndromes such as multiple endocrine
neoplasia (MEN) I and II, VHL syndrome and neurofibro-
matosis type I (NF-I).
Imaging approach
There is limited information in the pediatric literature regard-
ing the imaging findings of NETs. Most of the information
regarding imaging of these tumors is obtained from adult
studies. The quoted diagnostic performance of different
imaging modalities in various studies is highly variable
depending on local expertise, different stages of technology
development, and the imaging protocols used. A multi-
modality imaging approach using both anatomic and
molecular imaging is essential for detection, staging, and
surveillance of these tumors [5].
Anatomic imaging
Multidetector CT Multidetector CT (MDCT) has been
shown to have an accuracy of 92% and 96% for the detection
of primary tumor and metastasis, respectively [6]. The
advantages of MDCT include high temporal and spatial
resolution, acquisition of isotropic data resulting in high-
quality reformatted images, and bolus-tracking capability
resulting in precise timing of the scan. However, it is
imperative that the radiologist select appropriate imaging
parameters (tube current, gantry rotation time, kilovoltage,
table speed and detector configuration) to achieve a balance
between image quality and radiation exposure [7]. Although
in general multiphase examinations should be avoided in
children to keep radiation exposure as low as is reasonably
achievable (ALARA), optimal evaluation of NETs requires
dual-phase imaging. Images are obtained during arterial and
portal venous phases of enhancement after administration
of intravenous contrast agent at a rate of 3–5 ml/s (Fig. 1).
The appropriate delay after contrast agent injection and
before scanning will vary with the size of the patient. In an
average teenager, there will be a delay of approximately
25 s for the arterial phase and a delay of 60 to 70 s for
visualization of the portal vein. This aids detection of
NETs, which often demonstrate early enhancement with
washout during the portal venous phase because of their
hypervascular nature. Visualization of mural masses can be
improved by using water as an oral contrast agent. MDCT
can also be used to perform small-bowel enteroclysis to
detect small mural and luminal lesions of gut NETs [8].
Fig. 1 A 6-year-old girl with history of abdominal pain and diarrhea
for several months. Contrast-enhanced axial CT image in the arterial
phase (a) demonstrates multiple enhancing liver lesions (arrows) that
are difficult to discern on the portal venous phase (b) consistent with
hypervascular metastases. Also note the thickening of the gastric folds
due to elevated gastrin levels. Fine-needle aspiration of a liver lesion
confirmed metastatic gastrinoma
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metastasis [9]. Arterial phase images after contrast agent
administration and fat-suppressed fast spin echo T2-W
images are the most sensitive in detecting liver lesions
because of their hypervascular nature (Fig. 2). For the
detection of pancreatic lesions, MRI has been shown to
have a sensitivity of 94%, with the tumor being most
conspicuous on fat-saturated T1-W images [10].
Sonography Although traditional transabdominal US
examinations have low sensitivity in detection of small
tumors, contrast-enhanced, endoscopic, and intraoperative
US examinations have been reported to have higher
sensitivities in the detection of small lesions [9]. Endo-
scopic US with color Doppler imaging has been shown to
have sensitivities in the range of 79–100% for the detection
of small lesions in the pancreas head [11]. Intraoperative
US examinations have also been shown to improve the
accuracy of lesion detection to 97% in the pancreatic head
(Fig. 3)[ 12].
Molecular imaging
The overexpression of somatostatin receptors and the
presence of amine uptake and storage mechanisms allows
targeted molecular imaging of NETs using somatostatin
receptor scintigraphy (SRS) and metaiodobenzylguanidine
(MIBG), respectively. The sensitivity of octreotide and
MIBG scintigraphy is known to range between 78% and
100% and 36% and 85%, respectively [13].
111Indium
diethylenetriaminepentaacetate (DTPA) octreotide is the
most widely used radiopharmaceutical for SRS of NETs
Fig. 2 A 14-year-old boy after
resection of a bronchial NEC.
Axial T1-W image (a) demon-
strates a hypointense liver lesion
that is moderately hyperintense
on the T2-W image (b). Arterial
phase image after gadolinium
administration (c) shows intense
early enhancement with wash-
out to isointensity on the portal
venous phase images (d), con-
sistent with hypervascular me-
tastasis
Fig. 3 A 21-year-old man with severe gastroesophageal reflux disease
for 5 years and elevated gastrin levels of 5,258 pg/ml (normal range
0–100 pg/ml). Intraoperative US image shows a 3×3 cm hypoechoic
mass in the pancreas (arrow) closely abutting the splenic vein (V).
Surgical resection confirmed pancreatic gastrinoma
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these tumors (Fig. 4)[ 14]. Octreotide has high affinity for
somatostatin receptors, especially subtype 2, resulting in
good correlation between scintigraphic findings and the
expression of somatostatin receptors on these tumors as
determined by immunostaining. These receptors can also be
targeted for radiotherapy with radiolabeled somatostatin
analogues [14].
Positron emission tomography (PET) has the advantage
of high sensitivity, reasonable resolution, and the ability to
perform whole-body scans (Fig. 5).
18Fluorodeoxyglucose
(FDG) is the most widely used tracer but has limited sen-
sitivity in detection of well-differentiated and slow-growing
Fig. 4 A 6-year-old girl with a history of abdominal pain and diarrhea
for several months (same patient as in Fig. 2). SRS SPECT image (a)
obtained 24 h after intravenous administration of indium 111
pentatreotide in the coronal plane shows multiple foci of increased
uptake in the liver (arrowhead) with an intense focus inferior to the
liver (arrow), which corresponds to the exophytic lesion arising from
the pancreatic neck (arrow) seen on the coronal reformatted CT image
(b). This is a surgically proven gastrinoma. c Photomicrograph of
immunohistochemistry slide shows positive staining (brown)f o r
somatostatin receptors
Fig. 5 A 21-year-old male with history of metastatic neuroendocrine
carcinoma with unknown primary. a, b 18-FDG PET images in the
coronal plane demonstrate multifocal uptake in the left humerus,
bilateral ribs, liver, iliac wings, and both femurs consistent with
widespread metastatic disease
Fig. 6 A 19-year-old male after resection of bronchial NEC 7 years
previously. a Surveillance CT demonstrates expansion of the left
sacral neural foramen by a soft-tissue mass (arrow). b FDG-PET
demonstrates the lesion to be FDG avid raising the suspicion of tumor.
Surgical resection confirmed metastasis to the left S1 nerve sheath
254 Pediatr Radiol (2008) 38:251–259tumors [15]. PET using novel tracers such as 6-[fluoride-18]
fluoro-levodopa (
18F-DOPA), a catecholamine precursor,
shows promise in the evaluation of NETs [16].
Fusion imaging
Coregistration of molecular and anatomic modalities
with SPECT-CT or PET-CT can aid in accurate locali-
zation of disease and areas of physiologic uptake (Figs. 6
and 7). Fusion imaging with SPECT-CT has been shown
to be more accurate than either SPECT or CT alone and
resulted in management changes in 28% of patients in one
series [17].
Common pediatric GEP-NETs by location
Appendiceal NETs
Appendiceal NETs are the most common pediatric GEP-
NETs [2]. While appendiceal NETs in adults are generally
incidentally detected, 78–97% of appendiceal NETs in
children are associated with appendicitis (Fig. 8)[ 18–20].
In a series of 36 children with appendiceal carcinoids, the
median age at diagnosis was 12.3 years, and three-fourths
presented with acute appendicitis while the rest presented
with chronic abdominal pain [21]. Although carcinoid
syndrome has been reported in association with appendiceal
NETs in adults, the largest series of these tumors in children
failed to show any children with symptoms of carcinoid
syndrome [18, 20]. These tumors occur primarily at the
appendix tip and are generally less than 2 cm in size. The
long-term prognosis is good, with metastatic disease being
unusual in children with appendiceal NETs, as shown in
two large series with a median follow-up of 10–26 years
[18, 21]. However, appendiceal carcinoids with synchro-
nous and metachronous adenocarcinoma of the colon have
been reported, even in children [2, 18].
Gastrointestinal NETs
GEP-NETs in other parts of the gastrointestinal tract are less
common in children. Duodenal NETs arise from gastrin cells
and tend to produce Zollinger-Ellison syndrome [22]. Duode-
nal carcinoids are most common in the proximal duodenum
and present as early enhancing intraluminal polyps or mural
masses [23]. Unlike duodenal NETs, jejunal and ileal NETs
Fig. 7 A 16-year-old boy after
resection of pancreatic gastri-
noma 7 years previously with
recurrent symptoms of gastro-
esophageal reflux disease. a, b
Coregistered SRS SPECT and
contrast-enhanced CT images
allow accurate localization of
radionuclide uptake to a para-
caval lymph node (arrow) and a
perigastric (arrowhead) lymph
node, both of which are less
than 1 cm in short axis. Also
note multiple hepatic metastases
with intense octreotide uptake
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can cause carcinoid syndrome. Serotonin production results
in imaging findings of mesenteric desmoplasia, bowel
kinking, elastic vascular sclerosis, and intestinal ischemia
[8]. Ileal NETs might present with abdominal pain or diarrhea
secondary to increased intestinal motility or obstruction
secondary to intussusception. In the hindgut, the most
common location of NETs is the rectum. Most of these
tumors are nonfunctional, with rectal NETs having a better
prognosis than NETs in other parts of the colon.
Hepatic NETs
The liver is a common site of extra-appendiceal NETs in
children. In a series of 13 children with extra-appendiceal
NETs, the liver was the second most common site of disease
(5 of 13 children) [1]. It is unclear whether these tumors
represent true primary hepatic neoplasms or metastases from
asymptomatic occult NETs. Like the primary NETs, liver
lesions are hypointense on T1-W images, hyperintense on
T2-W images, and demonstrate arterial phase enhancement.
Pancreatic NETs
Pancreatic NETs account for approximately 30% of pan-
creatic tumors in patients younger than 20 years. While
insulinomas are the most common in adults, gastrinomas
are more common in children. Hypersecretion of gastrin
by gastrinomas causes recurrent or ectopic peptic ulcers
Fig. 8 A 21-year-old female with a history of right lower quadrant
pain for 6 days. a Contrast-enhanced axial CT image demonstrates a
distended (13 mm) non-opacified appendix (arrow) with minimal
periappendiceal stranding. b Gross specimen of the appendix
demonstrates obliteration of the lumen by the pale tumor that extends
through the wall into the serosa near the tip (arrow)
Fig. 9 A 21-year-old female
with history of VHL disease.
a, b Contrast-enhanced axial CT
images during arterial phase
demonstrate an enhancing mass
in the body of the pancreas
(arrow). A second mass located
in the uncinate process (arrow-
head) adjacent to the portal vein
was missed on initial reading.
c, d FDG-PET axial images
demonstrate two metabolically
active foci in the pancreas,
confirmed to be nonfunctional
NETs at surgery
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Mostgastrinomasaresolitarylesionslocatedinthegastrinoma
triangle, formed by the junction of the pancreatic neck and
body, the second and third parts of the duodenum, and the
junctionofthecysticandcommonbileducts.Nongastrinoma
neuroendocrine tumors can occur in any part of the pancreas
[24]. Metastases are present in 60–80% of patients at initial
diagnosis of gastrinoma, with the liver and lymph nodes
being the most common sites of metastatic disease [25].
Most neuroendocrine tumors of the pancreas are hypo-
intense on fat-suppressed T1-W images, moderately hyper-
intense to the pancreas on T2-W fat-suppressed images, and
show moderately intense early enhancement [24]. Patients
with familial NETs, such as MEN and VHL disease, might
present with multiple tumors with the majority being
nonfunctional (Fig. 9).
Pulmonary NETs
Pulmonary NETs are the most common extra-appendiceal
NETs in children [1]. They are also the most common
primary pulmonary neoplasm of childhood, accounting for
between 16% and 80% of malignant lung tumors in this
population [1, 26]. Children with these tumors tend to
present with wheezing and atelectasis, in addition to the
classic adult triad of cough, hemoptysis, and obstructive
pneumonitis [27]. Most present in late adolescence, though
these tumors have been reported in children as young as
3 years [28]. Patients might be symptomatic for approxi-
mately a year prior to diagnosis [27]. Bronchial carcinoids
in children tend to arise in the main, lobar, or segmental
bronchi, in regions of bronchial bifurcation. They typically
present as hilar or perihilar masses, with associated findings
of endobronchial obstruction such as air-trapping, atelecta-
sis, mucus-plugging, and obstructive pneumonitis (Fig. 10).
The mass is usually a well-defined round or ovoid homo-
geneously enhancing lesion with slightly lobulated margins.
The intense enhancement of the tumor is helpful for differ-
entiating the mass from adjacent postobstructive parenchy-
mal changes (Fig. 10). Calcification might be present in up
to 30% at histologic analysis. Carcinoid syndrome is unusual
with bronchial NETs unless they have metastasized to the
liver or are large in size with systemic drainage [29]. Intra-
operatively, these tumors can release vasoactive mediators
such as 5-hydroxyindoleacetic acid (5-HIAA), resulting in
carcinoidcrisischaracterizedbybronchospasm,hypotension,
acidosis, and ventricular tachycardia. If the diagnosis of a
NET is considered preoperatively, the life-threatening com-
RFig. 10 A 20-year-old man with a history of “asthma” and recurrent
pneumonia for 2 years. a Chest radiograph demonstrates right base
consolidation and right pleural effusion with an in-dwelling chest
tube. b Contrast-enhanced axial CT image demonstrates an enhancing
right hilar mass (arrow) with right lower lobe obstructive pneumonitis.
c Lung section at lobectomy demonstrates a fleshy circumscribed
mass (arrow) with a small endobronchial and larger extraluminal
component. The lung parenchyma is filled with cheesy purulent
material (arrowhead) secondary to obstructive pneumonitis
Pediatr Radiol (2008) 38:251–259 257plication of carcinoid crisis can be prevented by pretreatment
with octreotide [30].
Thymic NETs
Thymic NETs tend to be more aggressive than other
foregut tumors and often have metastatic disease at initial
presentation [9]. Not much is known about thymic
carcinoids in children; adult studies have shown that while
bronchial carcinoids are malignant in about 26% of
patients, thymic carcinoids can be malignant in about 80%
of patients [31]. They can present with local symptoms
(such as superior vena cava syndrome), can be incidentally
detected on radiographs, and can produce Cushing
syndrome (Fig. 11).
Middle ear NETs
NETs can also occur in the middle ear cavity, which is a
derivative of the first pharyngeal pouch of the foregut
(Fig. 12). Typical presenting symptoms of middle ear NETs
include hearing loss, aural fullness, and tinnitus. Physical
Fig. 11 A 17-year-old female with an incidentally detected anterior
mediastinal mass. a, b Axial contrast-enhanced CT images after
biopsy demonstrate an infiltrating soft-tissue mass in the anterior
mediastinum with enlarged pretracheal, subcarinal and hilar lymph
nodes, and pleural studding (arrow). c Bone window image demon-
strates multiple sclerotic lesions in the vertebral body, sacrum, and
iliac wings consistent with metastatic disease. d Photomicrograph of
H&E-stained section shows round cells with regular nuclei and salt-
and-pepper chromatin. e, f Immunostaining is positive for the neuro-
endocrine tumor markers chromogranin (e) and synaptophysin (f)
Fig. 12 A 13-year-old boy with
a history of a mass behind the
left tympanic membrane. a, b
Axial CT images through the
middle ear cavity demonstrate a
soft-tissue mass centered post-
erosuperior to the ossicles. Sur-
gical resection led to a diagnosis
of well-differentiated NET
258 Pediatr Radiol (2008) 38:251–259examination might reveal a mass behind the tympanic
membrane. The imaging and histologic characteristics of
these tumors can mimic those of paragangliomas. Although
middle ear NETs are typically low-grade malignancies that
have an indolent course, there is a 22% risk of recurrence
and 9% risk of metastatic disease [32].
Conclusions
AlowindexofsuspicionforGEP-NETsinchildrencombined
with nonspecific clinical complaints can result in delay in the
detection of these rare but treatable malignancies. A multi-
modality imaging approach using both anatomic and func-
tional imaging is essential in the diagnosis, staging, and
surveillance of these potentially malignant tumors in children.
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